Identifai Genetics Limited (ASX:ID1)
Australia · Delayed Price · Currency is AUD 0.4800
-0.0050 (-1.03%)
Oct 23, 2026, 4:11 PM AEDT
Identifai Genetics Market Cap
Identifai Genetics has a market cap or net worth of 92.15 million as of October 22, 2026. It is the 28,246th most valuable company in the world and the 622nd biggest in Australia.
Market Cap
92.15M
Enterprise Value
91.19M
Revenue
n/a
Global Rank
Country Rank
#622 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since October 13, 2026, Identifai Genetics's market cap has increased from 47.99M to 92.15M, an increase of 92.00%. That is a compound annual growth rate of 2,190,255,392,247.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 92.15M | -1.03% |
| Oct 22, 2026 | 93.11M | -3.00% |
| Oct 21, 2026 | 95.99M | 1.01% |
| Oct 20, 2026 | 95.03M | 15.12% |
| Oct 19, 2026 | 82.55M | 7.50% |
| Oct 16, 2026 | 76.79M | -11.11% |
| Oct 15, 2026 | 86.39M | 34.33% |
| Oct 14, 2026 | 64.31M | 34.00% |
| Oct 13, 2026 | 47.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 782.23M |
| Australian Clinical Labs | 539.41M |
| Healius | 299.54M |
| Monash IVF Group | 281.51M |
| Cryosite | 61.26M |
| BCAL Diagnostics | 28.76M |
| Rhythm Biosciences | 23.71M |
| Microba Life Sciences | 23.11M |